AstraZeneca said on Monday that a late‑stage trial testing its blockbuster therapy Imfinzi in combination with its ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

Peluntamig targets DLL3 and CD47, potentially enhancing immune recognition and attack on cancer cells. The SKYBRIDGE study is a phase 1/2 trial assessing peluntamig's safety and efficacy in ...

The pharmaceutical company said its ceralasertib combination didn’t meet the primary goal of a late-stage clinical trial for ...

Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Study OverviewThis study, officially titled “KEYMAKER-U01 ...

Please provide your email address to receive an email when new articles are posted on . DREAM program at Northwestern offers lung transplants to patients with advanced, localized lung cancer. Patients ...

This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...

As the rates of late-stage lung cancer in nonsmokers rise in Canada, researchers are advocating for increased awareness and screening. According to the Canadian Cancer Society, lung cancer was ...

“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...

AstraZeneca said on Monday that a late‑stage trial testing Imfinzi in combination with ceralasertib failed to improve overall survival versus standard treatments in patients with previously treated ...